LBA12 PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer. - Mayer, E.L.; Gnant, M.I.; DeMichele, A.; Martin, M.; Burstein, H.; Prat, A.; Rubovszky, G.; Miller, K.D.; Pfeiler, G.; Winer, E.P.; Zdenkowski, N.; Anderson, D.; et al. (Annals of Oncology, 2020)